Ozempic, the diabetes medication turned weight-loss sensation, has taken India by storm despite its official unavailability in the country. The semaglutide-based injection, known for its appetite-suppressing effects, has gained immense popularity among wealthy Indians and celebrities seeking rapid weight loss. However, the drug’s gray market proliferation and potential health risks have raised concerns among medical experts. Gray Market Demand and Celebrity Influence The global shortage of Ozempic has not deterred Indians from obtaining the coveted drug. Affluent individuals are resorting to importing Ozempic from Europe or purchasing counterfeit versions through online channels. Dr. Anjali Hooda, a famous Instagram doctor based … Continue reading Ozempic Weight-Loss Craze Hits India’s Gray Market: A Global Obesity Drug Sparks Serious Health Risk Concerns as Celebs Drive Demand